Replies to post #305594 on Avid Bioservices Inc (CDMO)

[biopharm]

”Combining Bavi w/anti-PD-1 significantly enhanced O/S…
significantly increases CD45+, CD8+ and CD3+ T-cells…
led a prolonged anti-tumor immune response which
protected the animals against a re-challenge w/same tumor.”

Thanks CJ and I don't know how often any BP has attempted to re-challenge and find success like this....but I remember reading here by those who attended Dr Rolf Brekken at NYAS a few years back that Dr Brekken mentioned that the late Dr Thorpe lab did just this and mice died of old age

Vaccines require such MOAs of PS Targeting